
Wake Forest University School of Medicine/LinkedIn
Jun 14, 2025, 06:53
Ruben Mesa: Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared a post on LinkedIn:
“Excited to be a co-investigator of the MANIFEST2 trial presented by Alessandro Vannucchi at EHA25. The 72-week data of the combination of Pelabresib plus Ruxolitinib showed durably superior responses for the combination for control of splenomegaly and dual responders.”
More posts featuring Ruben Mesa.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 14, 2025, 06:41
Jun 14, 2025, 06:24
Jun 14, 2025, 05:22
Jun 14, 2025, 04:51